IBRITUMOMAB TIUXETAN

1523 reported adverse events

These side effects are most commonly reported by patients taking IBRITUMOMAB TIUXETAN:

# Side effect Count
0 THROMBOCYTOPENIA 174
1 SEPSIS 172
2 NEUTROPENIA 141
3 MENINGITIS TUBERCULOUS 128
4 MYELODYSPLASTIC SYNDROME 98
5 FEBRILE NEUTROPENIA 94
6 OFF LABEL USE 93
7 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 90
8 DISEASE PROGRESSION 85
9 ANAEMIA 84
See all common reactions for IBRITUMOMAB TIUXETAN

IBRITUMOMAB TIUXETAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MENINGITIS TUBERCULOUS 128 0.2290
1 HEPATIC ANGIOSARCOMA 6 0.0822
2 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 5 0.0410
3 ERYTHROLEUKAEMIA 3 0.0395
4 5Q MINUS SYNDROME 4 0.0250
5 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 7 0.0224
6 REFRACTORY ANAEMIA 4 0.0217
7 TUMOUR ULCERATION 5 0.0211
8 BODY TEMPERATURE 5 0.0187
9 NON-HODGKIN'S LYMPHOMA 23 0.0176
See all enriched reactions for IBRITUMOMAB TIUXETAN